Table I.
Association between clinicopathological features and S100A16 expression in 104 patients with colorectal cancer.
| S100A16 expression | |||||
|---|---|---|---|---|---|
| Variables | n | Low (n=71) | High (n=33) | χ2 | P-value |
| Age, years | 0.280 | 0.596 | |||
| ≤50 | 19 | 12 | 7 | ||
| >50 | 85 | 59 | 26 | ||
| Sex | 0.000 | 0.987 | |||
| Female | 44 | 30 | 14 | ||
| Male | 60 | 41 | 19 | ||
| Pathological differentiation | 6.638 | 0.036 | |||
| I (high) | 11 | 7 | 4 | ||
| II (moderate) | 49 | 28 | 21 | ||
| III (poor) | 44 | 36 | 8 | ||
| T classification | 0.133 | 0.715 | |||
| T1 + T2 | 6 | 5 | 1 | ||
| T3 + T4 | 98 | 66 | 32 | ||
| N classification | 4.477 | 0.034 | |||
| N0 | 60 | 36 | 24 | ||
| N1 + N2 | 44 | 35 | 9 | ||
| AJCC stage | 3.311 | 0.069 | |||
| I + II | 59 | 36 | 23 | ||
| III + IV | 45 | 35 | 10 | ||
S100A16, S100 calcium binding protein A16. AJCC, American Joint Committee on Cancer.